Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Moodys
Baxter
Cipla
AstraZeneca
Citi
Cantor Fitzgerald
US Army

Generated: September 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019641

« Back to Dashboard

NDA 019641 describes TERAZOL 3, which is a drug marketed by Janssen Pharms and is included in two NDAs. It is available from three suppliers. Additional details are available on the TERAZOL 3 profile page.

The generic ingredient in TERAZOL 3 is terconazole. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the terconazole profile page.
Summary for 019641
Tradename:TERAZOL 3
Applicant:Janssen Pharms
Ingredient:terconazole
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUPPOSITORY;VAGINALStrength80MG
Approval Date:May 24, 1988TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Cerilliant
Merck
Deloitte
Harvard Business School
Colorcon
Mallinckrodt
Covington
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.